/West%20Pharmaceutical%20Services%2C%20Inc_%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. Valued at $19.8 billion by market cap, the company’s technologies include the design and manufacture of packaging components, research and development of drug delivery systems, and contract laboratory services and other services. The leading manufacturer of containment and delivery systems is expected to announce its fiscal fourth-quarter earnings for 2025 in the near term.
Ahead of the event, analysts expect WST to report a profit of $1.83 per share on a diluted basis, up marginally from $1.82 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
